IFNa10
Reaktivität: Human
WB, ELISA, IF (cc), IF (p), IHC (fro), IHC (p)
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000,ELISA 1:5000-20000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
1 mg/mL
Buffer
PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 %BSA
Konservierungsmittel
ProClin
Vorsichtsmaßnahmen
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
-20 °C
Informationen zur Lagerung
Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Haltbarkeit
12 months
Target
IFNA10 (IFNa10)
(Interferon, alpha 10 (IFNa10))
Andere Bezeichnung
IFN10
Hintergrund
Interferon alpha-10, IFN-alpha-10, Interferon alpha-6L, Interferon alpha-C, LeIF CIFNA10 (Interferon Alpha 10) is a Protein Coding gene. Diseases associated with IFNA10 include Visual Cortex Disease and Visual Pathway Disease. Among its related pathways are Response to elevated platelet cytosolic Ca2+ and RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways. IFNA10 encodes a protein that belongs to the type I interferon family of proteins, and is located in a cluster of alpha interferon genes on chromosome 9. Interferons are small regulatory molecules that function in cell signaling in response to viruses and other pathogens or tumor cells. IFNA10 is intronless and the encoded protein is secreted